This is the authors' abstract. We don't add key points for this paper.
Pharmacologic alterations of the inflammatory response and collagen metabolism will lead to control of the many disease states of fibrosis. Many of these diseases kill and cripple far more than hypertrophic scar. Far too little research is being directed in this area. The objectives of controlling fibrosis by interfering with collagen crosslinking were defined clearly by Peacock. Perhaps topical BAPN will be the first agent to bring a practical clinical reality to his predictions made over 20 years ago.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
I. KELMAN COHEN (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: